Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Shoker

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Pharmacotherapy|July 1, 1996
Immunopharmacologic therapy in renal transplantationA S Shoker
Clinical Chemistry|July 1, 1994
Application of the clearance concept to hyponatremic and hypernatremic disorders: a phenomenological analysisA S Shoker
Kidney International|September 12, 1998
Malnutrition and dialysisM A Baltzan, A S Shoker
Transplantation|July 27, 1995
The differential effect of alloantigen-blocking antibodies on unprimed and memory T helper cellsA S Shoker, D Sheridan, J Kalra
Clinical Nephrology|August 26, 1998
In vitro IgG1 alloreactive antibody production by circulating memory cells in humansK Okasha, H Yang, A S Shoker
Transplantation Proceedings|December 21, 2002
Relative contribution of HLA disparity to chronic allograft nephropathyM A Baltzan, A S Shoker, M A Baltzan
Transplantation Proceedings|November 13, 2003
Prevention of CAN graft loss in the medium term without HLA disparity reductionM A Baltzan, A S Shoker, M A Baltzan
Clinical Nephrology|February 1, 1997
Protein malnutrition and decreased protein turnover in chronic renal allograft failureM A Baltzan, A S Shoker, R B Baltzan
Transplantation Proceedings|December 27, 2012
A retrospective study of the Framingham cardiovascular risk scores in a liver transplant populationH Mansell, L J Worobetz, T Sylwestrowicz, et al.
Transplant Immunology|April 24, 2001
Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody productionA S Shoker, Z R Lun, R Choudry, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmacotherapy|July 1, 1996
Immunopharmacologic therapy in renal transplantationA S Shoker
Clinical Chemistry|July 1, 1994
Application of the clearance concept to hyponatremic and hypernatremic disorders: a phenomenological analysisA S Shoker
Kidney International|September 12, 1998
Malnutrition and dialysisM A Baltzan, A S Shoker
Transplantation|July 27, 1995
The differential effect of alloantigen-blocking antibodies on unprimed and memory T helper cellsA S Shoker, D Sheridan, J Kalra
Clinical Nephrology|August 26, 1998
In vitro IgG1 alloreactive antibody production by circulating memory cells in humansK Okasha, H Yang, A S Shoker
Transplantation Proceedings|December 21, 2002
Relative contribution of HLA disparity to chronic allograft nephropathyM A Baltzan, A S Shoker, M A Baltzan
Transplantation Proceedings|November 13, 2003
Prevention of CAN graft loss in the medium term without HLA disparity reductionM A Baltzan, A S Shoker, M A Baltzan
Clinical Nephrology|February 1, 1997
Protein malnutrition and decreased protein turnover in chronic renal allograft failureM A Baltzan, A S Shoker, R B Baltzan
Transplantation Proceedings|December 27, 2012
A retrospective study of the Framingham cardiovascular risk scores in a liver transplant populationH Mansell, L J Worobetz, T Sylwestrowicz, et al.
Transplant Immunology|April 24, 2001
Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody productionA S Shoker, Z R Lun, R Choudry, et al.
Pageof 2